Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal condition that is characterized by an overproduction of inflammatory cytokines by the immune system. Progressive illness, septic shock, and death can occur if the disease is not diagnosed and treatment initiated early. The authors describe the presentation, differential diagnosis, and evidence-based interprofessional management of HLH in a 1,200-bed Magnet®-designated institution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Obstetric, Gynecologic & Neonatal Nursing
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
